{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:23:19Z","timestamp":1785853399760,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12325-023-02765-x","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T02:01:20Z","timestamp":1704679280000},"page":"932-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative Safety of Pulsed Field Ablation and Cryoballoon Ablation Technologies for Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: A Critical Literature Review and Indirect Treatment Comparison"],"prefix":"10.1007","volume":"41","author":[{"given":"Sonia","family":"Maccioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reecha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-8198","authenticated-orcid":false,"given":"Donghyun D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Haltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vijgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"issue":"5","key":"2765_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"12","key":"2765_CR2","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","volume":"36","author":"JG Andrade","year":"2020","unstructured":"Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Can J Cardiol. 2020;36(12):1847\u2013948.","journal-title":"Can J Cardiol"},{"issue":"4","key":"2765_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","volume":"2","author":"H Calkins","year":"2009","unstructured":"Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349\u201361.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"2765_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00392-018-1232-4","volume":"107","author":"MI Murray","year":"2018","unstructured":"Murray MI, Arnold A, Younis M, Varghese S, Zeiher AM. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018;107(8):658\u201369.","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"2765_CR5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/clc.24092","volume":"46","author":"Z Liu","year":"2023","unstructured":"Liu Z, Yang Z, Lu Y, Wang H, Zou C. Short-term and long-term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2023;46(10):1146\u201353.","journal-title":"Clin Cardiol."},{"issue":"3","key":"2765_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jacep.2019.10.014","volume":"6","author":"SY Sarairah","year":"2020","unstructured":"Sarairah SY, Woodbury B, Methachittiphan N, Tregoning DM, Sridhar AR, Akoum N. Esophageal thermal injury following cryoballoon ablation for atrial fibrillation. JACC Clin Electrophysiol. 2020;6(3):262\u20138.","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"2765_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/europace\/euy121","volume":"21","author":"FJ Ha","year":"2019","unstructured":"Ha FJ, Han HC, Sanders P, Teh AW, O\u2019Donnell D, Farouque O, et al. Prevalence and prevention of oesophageal injury during atrial fibrillation ablation: a systematic review and meta-analysis. Europace. 2019;21(1):80\u201390.","journal-title":"Europace"},{"issue":"1","key":"2765_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010516","volume":"15","author":"CH Heeger","year":"2022","unstructured":"Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F, et al. Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: results of the Worldwide YETI registry. Circ Arrhythm Electrophysiol. 2022;15(1): e010516.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"2765_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/europace\/eux219","volume":"20","author":"L Rottner","year":"2018","unstructured":"Rottner L, Fink T, Heeger CH, Schluter M, Goldmann B, Lemes C, et al. Is less more? Impact of different ablation protocols on periprocedural complications in second-generation cryoballoon based pulmonary vein isolation. Europace. 2018;20(9):1459\u201367.","journal-title":"Europace"},{"issue":"11","key":"2765_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jacep.2019.08.003","volume":"5","author":"K Tokutake","year":"2019","unstructured":"Tokutake K, Tokuda M, Yamashita S, Sato H, Ikewaki H, Okajima E, et al. Anatomical and procedural factors of severe pulmonary vein stenosis after cryoballoon pulmonary vein ablation. JACC Clin Electrophysiol. 2019;5(11):1303\u201315.","journal-title":"JACC Clin Electrophysiol"},{"key":"2765_CR11","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2022.45","volume":"12","author":"D Schaack","year":"2023","unstructured":"Schaack D, Schmidt B, Tohoku S, Bordignon S, Urbanek L, Ebrahimi R, et al. Pulsed field ablation for atrial fibrillation. Arrhythm Electrophysiol Rev. 2023;12: e11.","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"3","key":"2765_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011780","volume":"16","author":"M Duytschaever","year":"2023","unstructured":"Duytschaever M, De Potter T, Grimaldi M, Anic A, Vijgen J, Neuzil P, et al. Paroxysmal atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter integrated with a 3-dimensional mapping system: 1-year outcomes of the multicenter inspIRE study. Circ Arrhythm Electrophysiol. 2023;16(3): e011780.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"2765_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","volume":"7","author":"VY Reddy","year":"2021","unstructured":"Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of impulse, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614\u201327.","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"2765_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","volume":"74","author":"VY Reddy","year":"2019","unstructured":"Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74(3):315\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"2765_CR15","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","volume":"147","author":"A Verma","year":"2023","unstructured":"Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE, et al. Pulsed field ablation for the treatment of atrial fibrillation: Pulsed AF Pivotal trial. Circulation. 2023;147(19):1422\u201332.","journal-title":"Circulation"},{"issue":"9","key":"2765_CR16","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/europace\/euab090","volume":"23","author":"H Cochet","year":"2021","unstructured":"Cochet H, Nakatani Y, Sridi-Cheniti S, Cheniti G, Ramirez FD, Nakashima T, et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. Europace. 2021;23(9):1391\u20139.","journal-title":"Europace"},{"key":"2765_CR17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307291","author":"VY Reddy","year":"2023","unstructured":"Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. New Engl J Med. 2023. https:\/\/doi.org\/10.1056\/NEJMoa2307291.","journal-title":"New Engl J Med."},{"key":"2765_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"2765_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005318","author":"A Ferrero-de-Loma-Osorio","year":"2017","unstructured":"Ferrero-de-Loma-Osorio A, Garcia-Fernandez A, Castillo-Castillo J, Izquierdo-de-Francisco M, Ibanez-Criado A, Moreno-Arribas J, et al. Time-to-effect-based dosing strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation: results of the plusONE multicenter randomized controlled noninferiority trial. Circ Arrhythm Electrophysiol. 2017. https:\/\/doi.org\/10.1161\/CIRCEP.117.005318.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"12","key":"2765_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/jce.12846","volume":"26","author":"RJ Hunter","year":"2015","unstructured":"Hunter RJ, Baker V, Finlay MC, Duncan ER, Lovell MJ, Tayebjee MH, et al. Point-by-point radiofrequency ablation versus the cryoballoon or a novel combined approach: a randomized trial comparing 3 methods of pulmonary vein isolation for paroxysmal atrial fibrillation (The Cryo versus RF trial). J Cardiovasc Electrophysiol. 2015;26(12):1307\u201314.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"2765_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jacep.2018.11.006","volume":"5","author":"BP Knight","year":"2019","unstructured":"Knight BP, Novak PG, Sangrigoli R, Champagne J, Dubuc M, Adler SW, et al. Long-term outcomes after ablation for paroxysmal atrial fibrillation using the second-generation cryoballoon: final results from STOP AF post-approval study. JACC Clin Electrophysiol. 2019;5(3):306\u201314.","journal-title":"JACC Clin Electrophysiol"},{"issue":"38","key":"2765_CR22","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","volume":"37","author":"KH Kuck","year":"2016","unstructured":"Kuck KH, Furnkranz A, Chun KR, Metzner A, Ouyang F, Schluter M, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38):2858\u201365.","journal-title":"Eur Heart J"},{"issue":"1","key":"2765_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12872-017-0566-6","volume":"17","author":"A Luik","year":"2017","unstructured":"Luik A, Kunzmann K, Hormann P, Schmidt K, Radzewitz A, Bramlage P, et al. Cryoballoon vs. open irrigated radiofrequency ablation for paroxysmal atrial fibrillation: long-term FreezeAF outcomes. BMC Cardiovasc Disord. 2017;17(1):135.","journal-title":"BMC Cardiovasc Disord."},{"issue":"5","key":"2765_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/jce.12626","volume":"26","author":"VY Reddy","year":"2015","unstructured":"Reddy VY, Sediva L, Petru J, Skoda J, Chovanec M, Chitovova Z, et al. Durability of pulmonary vein isolation with cryoballoon ablation: results from the sustained PV isolation with arctic front advance (SUPIR) study. J Cardiovasc Electrophysiol. 2015;26(5):493\u2013500.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"2765_CR25","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/j.hrthm.2017.07.009","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm. 2017;14(10):e445\u201394.","journal-title":"Heart Rhythm"},{"key":"2765_CR26","unstructured":"Dias S, Sutton AJ, Welton NJ, Ades AE. Nice DSU technical support document 3: heterogeneity: subgroups, meta-regression, bias and bias-adjustment 2011 [updated April 2012. Available from: http:\/\/www.nicedsu.org.uk"},{"issue":"4","key":"2765_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","volume":"14","author":"DC Hoaglin","year":"2011","unstructured":"Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: Part 2. Value Health. 2011;14(4):429\u201337.","journal-title":"Value Health"},{"issue":"4","key":"2765_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","volume":"14","author":"JP Jansen","year":"2011","unstructured":"Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR task force on indirect treatment comparisons good research practices: Part 1. Value Health. 2011;14(4):417\u201328.","journal-title":"Value Health"},{"key":"2765_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1741-7015-11-159","volume":"11","author":"JP Jansen","year":"2013","unstructured":"Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013;11:159.","journal-title":"BMC Med"},{"issue":"3","key":"2765_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2307\/2530610","volume":"34","author":"D Katz","year":"1978","unstructured":"Katz D, Baptista J, Azen SP, Pike MC. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics. 1978;34(3):469\u201374.","journal-title":"Biometrics"},{"issue":"1","key":"2765_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2307\/2531960","volume":"43","author":"BJR Bailey","year":"1987","unstructured":"Bailey BJR. Confidence limits to the risk ratio. Biometrics. 1987;43(1):201\u20135.","journal-title":"Biometrics"},{"issue":"277","key":"2765_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/01621459.1957.10501366","volume":"52","author":"GE Noether","year":"1957","unstructured":"Noether GE. Two confidence intervals for the ratio of two probabilities and some measures of effectiveness. J Am Stat Assoc. 1957;52(277):36\u201345.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2765_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2307\/2531405","volume":"40","author":"PAR Koopman","year":"1984","unstructured":"Koopman PAR. Confidence intervals for the ratio of two binomial proportions. Biometrics. 1984;40(2):513\u20137.","journal-title":"Biometrics"},{"key":"2765_CR34","unstructured":"Signorell A, Alfons A, Anderegg N, Aragon T, Arachchige C, Arppe A, Baddeley A, Barton K, Bolker B et al. DescTools: Tools for Descriptive Statistics; R Package Version 0.99.44. 2021. Available online: https:\/\/CRAN.R-project.org\/package=DescTools (Accessed on 4 May 2023). 2021."},{"issue":"4","key":"2765_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"7","key":"2765_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/CIRCEP.123.011920","volume":"16","author":"L Urbanek","year":"2023","unstructured":"Urbanek L, Bordignon S, Schaack D, Chen S, Tohoku S, Efe TH, et al. Pulsed field versus cryoballoon pulmonary vein isolation for atrial fibrillation: efficacy, safety, and long-term follow-up in a 400-patient cohort. Circ Arrhythm Electrophysiol. 2023;16(7):389\u201398.","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02765-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:13:47Z","timestamp":1708452827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02765-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2765"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02765-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Donghyun D. Lee and Anja Haltner are employees of EVERSANA\u2122. EVERSANA\u2122 receives consultancy fees from major pharmaceutical and device companies, including Biosense Webster. Sonia Maccioni, Rahul Khanna, and Reecha Sharma are employees of Johnson & Johnson. Johan Vijgen reports research funding from Daiichi-Sackyo, BMS-Pfizer, Bayer, Biotronik, Boston Scientific, Medtronic, and Abbott. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}